Related Experiment Video
Updated: Jun 4, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
90
Fluorinated Coumarin Derivatives as Selective PET Tracer for MAO-B Imaging
Nan Wu1, Xiaojun Zhang2, Yuying Li1
1Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
Journal of Medicinal Chemistry
|December 19, 2024
Summary
Researchers developed a new PET tracer, [18F]8, for imaging monoamine oxidase-B (MAO-B). This tracer shows high affinity and good brain uptake, making it promising for diagnosing neurodegenerative diseases.
Area of Science:
- Neuroscience
- Radiochemistry
- Molecular Imaging
Background:
- Monoamine oxidase-B (MAO-B) is a key biomarker for reactive astrocytes in neuroinflammation and neurodegenerative diseases.
- MAO-B is located on the outer mitochondrial membrane of astrocytes.
Purpose of the Study:
- To synthesize novel fluorinated coumarin derivatives.
- To evaluate their structure-activity relationship and subtype selectivity for MAO-B.
- To identify a potential PET tracer for MAO-B imaging.
Main Methods:
- Synthesis of fluorinated coumarin derivatives.
- Structure-activity relationship and subtype selectivity evaluation.
- Preclinical bioevaluation using in vivo PET imaging and ex vivo autoradiography in rats.
- Inhibition studies with Selegiline.
Main Results:
- Identified a novel PET tracer, [18F]8, with high affinity for MAO-B (IC50 = 0.59 nM).
- [18F]8 demonstrated favorable brain pharmacokinetics in rats (SUVmax = 2.15 at 2 min, brain2min/60min = 7.67).
- Selegiline effectively inhibited radiolabeling in regions of MAO-B expression.
Conclusions:
- [18F]8 is a promising PET tracer candidate for MAO-B imaging.
- Further evaluation is warranted for its clinical application in neurodegenerative diseases.
Related Concept Videos
Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
81
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
81
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
